Bausch Health Companies Inc. BHC
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 9.60% | 12.82% | 12.26% | 9.49% | 7.05% |
| Total Other Revenue | 20.83% | 3.85% | -25.00% | -9.68% | -14.29% |
| Total Revenue | 9.70% | 12.73% | 11.73% | 9.26% | 6.81% |
| Cost of Revenue | -2.00% | 1.05% | 5.28% | 9.77% | 7.76% |
| Gross Profit | 14.24% | 17.78% | 14.63% | 9.06% | 6.45% |
| SG&A Expenses | 4.91% | 1.45% | -0.23% | 8.24% | -6.47% |
| Depreciation & Amortization | -10.28% | -12.11% | -5.86% | -8.88% | -7.66% |
| Other Operating Expenses | 66.67% | -- | -- | -- | -- |
| Total Operating Expenses | -1.17% | 0.19% | 2.09% | 5.76% | -0.41% |
| Operating Income | 39.14% | 69.58% | 75.42% | 20.77% | 32.90% |
| Income Before Tax | 173.85% | 148.57% | -2,780.85% | -73.21% | 1,138.10% |
| Income Tax Expenses | 308.11% | 633.33% | 97.44% | 43.24% | -47.89% |
| Earnings from Continuing Operations | 146.41% | 103.13% | -1,563.95% | -205.10% | 296.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -400.00% | -110.00% | -71.43% | -80.00% | -128.57% |
| Net Income | 143.58% | 74.32% | -2,353.45% | -220.43% | 310.59% |
| EBIT | 39.14% | 69.58% | 75.42% | 20.77% | 32.90% |
| EBITDA | 25.36% | 38.22% | 35.55% | 11.84% | 18.82% |
| EPS Basic | 140.84% | 72.43% | -2,332.82% | -220.00% | 308.97% |
| Normalized Basic EPS | 89.11% | 5,264.41% | 589.62% | 27.73% | 44.93% |
| EPS Diluted | 139.58% | 70.43% | -2,332.82% | -221.46% | 308.06% |
| Normalized Diluted EPS | 88.66% | 5,265.81% | 589.62% | 27.73% | 43.29% |
| Average Basic Shares Outstanding | 1.13% | 1.11% | 0.87% | 0.36% | 0.79% |
| Average Diluted Shares Outstanding | 1.38% | 1.34% | 0.87% | 0.36% | 1.93% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |